Thomas W Nerney
Visit Investigator ProfileInvestigation Details
Bruce G Cooper , Justine M Corson , Allison A Rodriguez , Mary-Jeanet Mcgarry , Edmund F Mrak , Slater K Bartlett , Stephen C King , Debra M Emerson , Almaris N Alonso , Philip Kreiter , Lauren M Lawrance , Pamela L Ogonowski , Rory Geyer , Douglas S Joslin , Pamela L Lee , Nichole B Murphy , Richard L Friedman , Amy C Jordan , Ashley M Whitehurst , Stacey S Degarmo , Ramon E Martinez
Detailed Analysis
Thomas W Nerney focuses on meticulous verification of process validation, complaint management, CAPA procedures, batch manufacturing, facility integrity, change control, and data integrity. He emphasizes the importance of thoroughness in investigations and adherence to established procedures.
Thomas W Nerney is a detail-oriented FDA auditor who places a high emphasis on process validation, complaint management, CAPA, batch manufacturing, facility management, change control, and data integrity management. He is particularly concerned about ensuring the consistency and quality of drug products through robust validation processes and thorough complaint investigations, as well as maintaining facility integrity to prevent contamination risks.
Unlock Insights from 483s & Stay Audit Ready with FDA Tracker
Monitor FDA Six Systems, Analyse 483s with Observations, Investigators & Companies